Digital Health Innovators – Brian Quigley and Mario Danek (Live from... At HLTH last month, pharmaphorum Editor in Chief Jonah Comstock sat down with the CEO and CTO respectively of QNovia, Brian Quigley and Mario Danek.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.